8-Week Starter Pack
Starter option for clients beginning a provider-guided Tirzepatide program.
Tirzepatide is a dual GIP and GLP-1 receptor agonist used in medical weight-management. Vydration offers provider-guided treatment options with appropriate consultation, screening, and individualized instructions.
Tirzepatide works through GIP and GLP-1 receptor pathways involved in appetite, digestion, and metabolic regulation.
Eligibility, dosing, escalation, and follow-up should be determined by a licensed clinician based on your health history and response to treatment.
Select an option to open the current product page, review available choices, and continue to purchase.
Starter option for clients beginning a provider-guided Tirzepatide program.
Monthly Tirzepatide package with available dose selection on the product page.
Single-vial Tirzepatide option for an eligible provider-guided treatment plan.
Eligibility is determined through health-history review and provider assessment.
When prescribed, Tirzepatide is generally used on a weekly schedule according to your clinician's instructions.
Your provider may adjust your treatment plan based on response, tolerance, and individual goals.
Book a consultation with the Vydration team to review eligibility and Tirzepatide options.